XTL-2125
200517-HMO-CTIL
Phase 1 small_molecule terminated
Quick answer
XTL-2125 for Chronic Hepatitis C Virus Infection is a Phase 1 program (small_molecule) at XTL BIOPHARMACEUTICALS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- XTL BIOPHARMACEUTICALS LTD
- Indication
- Chronic Hepatitis C Virus Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated